Grace Therapeutics
GRCE
9 hedge funds and large institutions have $743K invested in Grace Therapeutics in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
6% more capital invested
Capital invested by funds: $704K → $743K (+$39.1K)
0.01% more ownership
Funds ownership: 0.07% → 0.08% (+0.01%)
0% more funds holding
Funds holding: 9 → 9 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$41.1K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$31.4K |
| 3 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$187 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$18.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
1
Perceptive Advisors
New York
| $247K | – | – | – |
|
2
Bank of Montreal
Toronto,
Ontario, Canada
| $231K | – | – | – |
|
|
IIM
3
Intact Investment Management
Montreal,
Quebec, Canada
| $152K | – | – | – |
|
|
VKH
4
Virtu KCG Holdings
New York
| $42K | +$41.1K | +661 | New |
|
|
5
Renaissance Technologies
New York
| $36K | -$18.8K | -302 | -35% |
|
|
6
Citadel Advisors
Miami,
Florida
| $32K | +$31.4K | +505 | New |
|
|
FDCDDQ
7
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $2.78K | – | – | – |
|
|
8
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | +$187 | +3 | +300% |
|
GRCE Hedge Fund Activity: Q2 2017 in Review
9 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q2 2017, worth a combined $743K — up 5.5% from $704K a quarter earlier.
Fund positioning in GRCE was balanced in Q2 2017: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $41.1K. The largest seller was Renaissance Technologies, cutting an estimated $18.8K.
- 9 institutional investors held Grace Therapeutics (GRCE) as of Q2 2017, unchanged from Q1 2017.
- Funds reported $743K of Grace Therapeutics stock for Q2 2017, up 5.5% quarter-over-quarter.
- 2 funds opened new Grace Therapeutics positions in Q2 2017 and 2 closed out, a net change of 0 holders.
- The largest Grace Therapeutics buyer in Q2 2017 was Virtu KCG Holdings, an estimated $41.1K added.
- The largest Grace Therapeutics seller in Q2 2017 was Renaissance Technologies, an estimated $18.8K sold.
Based on aggregated 13F filings for Q2 2017.